Skip to main content
BrainAurora Medical Technology Limited logo

BrainAurora Medical Technology Limited — Investor Relations & Filings

Ticker · 6681 HKEX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 76 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6681

About BrainAurora Medical Technology Limited

http://66nao.cn

BrainAurora Medical Technology Limited specializes in the development and provision of medical-grade digital therapeutics (DTx) focused on the assessment and intervention of cognitive impairments. The company delivers system integral software solutions and a brain function information management platform, primarily serving hospitals to facilitate comprehensive cognitive evaluation and treatment services. BrainAurora's DTx pipeline addresses cognitive deficits stemming from various conditions, including vascular diseases, neurodegenerative diseases, psychological disorders, and childhood developmental defects. The company integrates brain science with advanced technology to offer evidence-based therapeutic interventions. BrainAurora is noted for being among the first companies in China to develop a medical-grade DTx product specifically for cognitive impairment, positioning its solutions as potential first-line treatments.

Recent filings

Filing Released Lang Actions
CLARIFICATION ANNOUNCEMENT RELATING TO ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2025
Regulatory Filings Classification · 1% confidence The document is a standalone announcement published on the Hong Kong Stock Exchange that provides clarification and corrections to an already published Annual Report. It does not itself contain the full annual financial statements (10-K) nor does it announce the initial release of the report. Instead, it amends specific clerical errors in the Annual Report tables. This type of miscellaneous regulatory announcement that does not fit another specific category falls under Regulatory Filings (RNS).
2026-04-29 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 18, 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a form of proxy relating to the Annual General Meeting, providing instructions for shareholders to appoint a proxy and vote on resolutions. This is not the AGM presentation materials themselves but rather materials soliciting votes and providing meeting information to shareholders. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the official notice of an Annual General Meeting (AGM) of BrainAurora Medical Technology Limited, detailing proxy appointment procedures, proposed resolutions, and voting instructions. It is not the actual annual report, earnings release, or presentation materials, but rather a solicitation of proxies and information statement for shareholders’ voting ahead of the AGM. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-28 English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERA
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a comprehensive shareholder circular containing detailed proposals, explanatory statements, definitions, board letters, appendices on retiring directors, and notice of the Annual General Meeting along with a proxy form. It is clearly intended to solicit shareholder votes and provide the necessary information ahead of the AGM. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-28 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Regulatory Filings
2026-04-28 English
2025 ANNUAL REPORT
Annual Report Classification · 1% confidence The document is titled “2025 ANNUAL REPORT” and contains all the hallmarks of a full year‐end annual report: a message from management (Business and Financial Highlights, Management Discussion and Analysis), Directors’ Report, Corporate Governance Report, Independent Auditor’s Report, consolidated financial statements (Statement of Profit or Loss, Statement of Financial Position, Statement of Cash Flows, Notes to the Consolidated Financial Statements), and a three-year financial summary. It is clearly the complete annual report rather than merely an announcement, fitting the Annual Report definition. FY 2025
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.